Regulated genetic suicide mechanism compositions and methods

Details for Australian Patent Application No. 2009262306 (hide)

Owner Vaxiion Therapeutics, Inc.

Inventors Maloy, Stanley; Tsuji, Shingo; Giacalone, Matthew J.

Agent Fisher Adams Kelly

Pub. Number AU-A-2009262306

PCT Pub. Number WO2009/158364

Priority 61/075,687 25.06.08 US; 61/168,457 10.04.09 US

Filing date 23 June 2009

Wipo publication date 30 December 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2009/158364 Priority application(s): WO2009/158364

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009262319-Salts of methyl 2-((R))-(3-chlorophenyl) ((R)-1-((S)-2- (methylamino)-3((R)-tetrahydro-2H-pyra n-3-yl) propylcarbamoyl) piperidin3-yl)methoxy)ethylcarbamate

2009262302-Rack tower for securing crossbars on top of a vehicle